Sandra Bialose
Psychiatric/Mental Health · Fort Worth, TXNPI 1891305827
Payments from drug & device makers
Across 458 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$810
- Lundbeck LLC$638
- Alkermes, Inc.$620
- plus $4K from 26 others
What the payments were for
- Food & beverage$9,189100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 61 | $1,273 |
| Johnson & Johnson | 36 | $1,090 |
| AbbVie | 80 | $1,082 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $810 |
| Lundbeck LLC | 34 | $638 |
| Alkermes, Inc. | 31 | $620 |
| Neurocrine Biosciences, Inc. | 18 | $594 |
| Corium, LLC | 21 | $473 |
| Sunovion Pharmaceuticals Inc. | 18 | $355 |
| Ironshore Pharmaceuticals Inc. | 16 | $260 |
| Teva Pharmaceuticals USA, Inc. | 8 | $255 |
| Axsome Therapeutics, Inc. | 11 | $241 |
| Supernus Pharmaceuticals, Inc. | 8 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $196 |
| Neos Therapeutics, LP | 9 | $171 |
| Janssen Scientific Affairs, LLC | 1 | $126 |
| Bausch Health US, LLC | 7 | $107 |
| Noven Therapeutics, LLC | 5 | $104 |
| Jazz Pharmaceuticals Inc. | 5 | $89 |
| Tris Pharma Inc | 5 | $87 |
| Almatica Pharma LLC | 4 | $72 |
| Adlon Therapeutics L.p. | 5 | $60 |
| Indivior Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Eisai Inc. | 1 | $21 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$248
- INVEGA SUSTENNA$241
- SPRAVATO$240
- QELBREE$144
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- Austedo XR$124
How this compares
$9,189 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Fort Worth
- Tamekia ScaggsFort Worth$80K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.